4.7 Editorial Material

What Can Be Inferred from the Interruption of the Semagacestat Trial for Treatment of Alzheimer's Disease?

Journal

BIOLOGICAL PSYCHIATRY
Volume 68, Issue 10, Pages 876-878

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.biopsych.2010.09.020

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available